These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15124696)

  • 1. Treatment of acute myeloid leukemia younger adults: the GOELAM experience.
    Harousseau JL;
    Ann Hematol; 2004; 83 Suppl 1():S104-5. PubMed ID: 15124696
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensified induction therapy for children with AML.
    Woods WG
    Ann Hematol; 2004; 83 Suppl 1():S119-20. PubMed ID: 15124701
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous bone marrow transplantation improves disease free survival but not overall survival in people with acute myeloid leukaemia.
    Chauncey TR
    Cancer Treat Rev; 2004 Aug; 30(5):483-7. PubMed ID: 15245781
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies in the treatment of acute myeloid leukemia.
    Lowenberg B
    Haematologica; 2004 Sep; 89(9):1029-32. PubMed ID: 15377460
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients.
    Isidori A; Bonifazi F; Visani G; Gherlinzoni F; Baccarani M; Lemoli RM
    Haematologica; 2005 Jan; 90(1):139-41. PubMed ID: 15642686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial.
    Breems DA; Boogaerts MA; Dekker AW; Van Putten WL; Sonneveld P; Huijgens PC; Van der Lelie J; Vellenga E; Gratwohl A; Verhoef GE; Verdonck LF; Löwenberg B
    Br J Haematol; 2005 Jan; 128(1):59-65. PubMed ID: 15606550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
    Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute myeloid leukemia.
    Woods WG; Sanders JE; Neudorf S
    N Engl J Med; 1999 May; 340(18):1437-9. PubMed ID: 10328705
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia.
    Buccisano F; Maurillo L; Del Poeta G; Gattei V; Amadori S; Venditti A
    Haematologica; 2006 Dec; 91(12 Suppl):ELT14; author reply ELT15. PubMed ID: 17194674
    [No Abstract]   [Full Text] [Related]  

  • 10. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
    Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
    Schlenk RF; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G
    J Clin Oncol; 2004 Sep; 22(18):3741-50. PubMed ID: 15289486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM
    Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research.
    Lazarus HM; Pérez WS; Klein JP; Kollman C; Bate-Boyle B; Bredeson CN; Gale RP; Geller RB; Keating A; Litzow MR; Marks DI; Miller CB; Douglas Rizzo J; Spitzer TR; Weisdorf DJ; Zhang MJ; Horowitz MM
    Br J Haematol; 2006 Mar; 132(6):755-69. PubMed ID: 16487177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. High Priority Trials.
    Cheson BD; Ungerleider RS
    Oncology (Williston Park); 1992 Oct; 6(10):57-8. PubMed ID: 1390015
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials in adult AML.
    Stock W
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):8-10. PubMed ID: 19645130
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation strategies in AML: AMLCG data.
    Kienast J; Stelljes M; Berning B; Kröger M; Sauerland MC; Heinecke A; Schoch C; Wörmann B; Büchner T; Hiddemann W; Berdel WE;
    Ann Hematol; 2004; 83 Suppl 1():S136-7. PubMed ID: 15124707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
    Farag SS; Ruppert AS; Mrózek K; Mayer RJ; Stone RM; Carroll AJ; Powell BL; Moore JO; Pettenati MJ; Koduru PR; Stamberg J; Baer MR; Block AW; Vardiman JW; Kolitz JE; Schiffer CA; Larson RA; Bloomfield CD
    J Clin Oncol; 2005 Jan; 23(3):482-93. PubMed ID: 15534356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
    Tauro S; Craddock C; Peggs K; Begum G; Mahendra P; Cook G; Marsh J; Milligan D; Goldstone A; Hunter A; Khwaja A; Chopra R; Littlewood T; Peniket A; Parker A; Jackson G; Hale G; Cook M; Russell N; Mackinnon S
    J Clin Oncol; 2005 Dec; 23(36):9387-93. PubMed ID: 16314618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.